$ARTL
ARTELO BIOSCIENCES, INC.

2022 Q3 Form 10-Q Financial Statement

#000164033422001681 Filed on August 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.316M $1.415M $1.482M
YoY Change 3.51% 8.83% 23.5%
% of Gross Profit
Research & Development $1.078M $1.056M $464.0K
YoY Change 75.15% 8.87% 51.14%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.394M $2.471M $1.946M
YoY Change 26.88% 9.63% 14.74%
Operating Profit -$2.394M -$2.471M -$1.946M
YoY Change 6.64% 9.63% 14.74%
Interest Expense $5.000K $22.00K -$19.00K
YoY Change -1662.5% 2144.9%
% of Operating Profit
Other Income/Expense, Net $64.00K $22.00K -$19.00K
YoY Change 11751.85% 1000.0% -2000.0%
Pretax Income -$2.330M -$2.449M -$1.965M
YoY Change 23.5% 8.85% 5.08%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.330M -$2.449M -$1.965M
YoY Change 23.5% 8.75% 15.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$817.8K -$865.2K -$696.8K
COMMON SHARES
Basic Shares Outstanding 42.59M shares 42.30M shares 42.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.624M $19.33M $21.51M
YoY Change -14.32% 92.32% 91.73%
Cash & Equivalents $7.136M $12.12M $10.35M
Short-Term Investments $1.488M $7.211M $11.16M
Other Short-Term Assets $820.0K $960.0K $1.078M
YoY Change 225.4% 287.11% 467.37%
Inventory
Prepaid Expenses $686.0K $826.0K $1.078M
Receivables
Other Receivables
Total Short-Term Assets $20.30M $22.28M $24.59M
YoY Change 96.79% 116.32% 115.59%
LONG-TERM ASSETS
Property, Plant & Equipment $70.00K $81.00K $73.00K
YoY Change -22.22% 134900.0% 58770.97%
Goodwill
YoY Change
Intangibles $2.039M $2.039M $2.039M
YoY Change 0.0% -0.02%
Long-Term Investments $0.00 $0.00 $0.00
YoY Change
Other Assets $3.000K $3.000K $3.000K
YoY Change -98.41%
Total Long-Term Assets $2.112M $2.123M $2.115M
YoY Change -8.89% 4.1% 3.7%
TOTAL ASSETS
Total Short-Term Assets $20.30M $22.28M $24.59M
Total Long-Term Assets $2.112M $2.123M $2.115M
Total Assets $22.42M $24.41M $26.70M
YoY Change 77.4% 97.78% 98.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $411.0K $432.0K $800.0K
YoY Change -16.63% 3.12% 37.93%
Accrued Expenses $42.00K $45.00K $32.00K
YoY Change 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $480.0K $527.0K $875.0K
YoY Change -8.75% 24.31% 48.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $32.00K $40.00K $49.00K
YoY Change -52.24%
Total Long-Term Liabilities $32.00K $40.00K $49.00K
YoY Change -52.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $480.0K $527.0K $875.0K
Total Long-Term Liabilities $32.00K $40.00K $49.00K
Total Liabilities $512.0K $567.0K $924.0K
YoY Change -13.66% 33.75% 56.61%
SHAREHOLDERS EQUITY
Retained Earnings -$27.68M -$25.35M -$22.90M
YoY Change 63.77% 79.4%
Common Stock $3.000K $42.00K $42.00K
YoY Change -88.0% 89.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.90M $23.84M $25.78M
YoY Change
Total Liabilities & Shareholders Equity $22.42M $24.41M $26.70M
YoY Change 77.4% 97.78% 98.62%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.330M -$2.449M -$1.965M
YoY Change 23.5% 8.75% 15.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.696M -$1.966M -$2.053M
YoY Change 10.04% 10.47% 17.85%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$3.080M $3.985M $257.0K
YoY Change -10.44% -150.39%
Cash From Investing Activities -$3.080M $3.985M $257.0K
YoY Change -10.44% 681.37% -112.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -134.0K $0.00
YoY Change -100.0% -121.78% -100.0%
NET CHANGE
Cash From Operating Activities -1.696M -1.966M -$2.053M
Cash From Investing Activities -3.080M 3.985M $257.0K
Cash From Financing Activities 0.000 -134.0K $0.00
Net Change In Cash -4.776M 1.885M -$1.812M
YoY Change 41.15% -388.02% -181.26%
FREE CASH FLOW
Cash From Operating Activities -$1.696M -$1.966M -$2.053M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Assets Current
AssetsCurrent
24609000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81000 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6250000 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
dei Entity Central Index Key
EntityCentralIndexKey
0001621221
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42301013 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42593981 shares
CY2022Q2 artl Available For Sale Security
AvailableForSaleSecurity
0 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2859184 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38951
dei Entity Registrant Name
EntityRegistrantName
ARTELO BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1220924
dei Entity Address Address Line1
EntityAddressAddressLine1
505 Lomas Santa Fe
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 160
dei Entity Address City Or Town
EntityAddressCityOrTown
Solana Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Country
EntityAddressCountry
US
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92075
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
925-7049
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
ARTL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42593981 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12122000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12162000 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
7211000 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
11951000 usd
CY2022Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1989000 usd
CY2021Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
0 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
826000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
496000 usd
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
134000 usd
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
0 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
22282000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039000 usd
CY2022Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
0 usd
CY2021Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1519000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3000 usd
CY2022Q2 us-gaap Assets
Assets
24405000 usd
CY2021Q4 us-gaap Assets
Assets
28251000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
432000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
975000 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
50000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
31000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
527000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1027000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
40000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
57000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
567000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1084000 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42301013 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49324000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48081000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25352000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20938000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-176000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23838000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
27167000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24405000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28251000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1415000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1284000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2897000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2673000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1056000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
970000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1520000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1277000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2471000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2254000 usd
us-gaap Operating Expenses
OperatingExpenses
4417000 usd
us-gaap Operating Expenses
OperatingExpenses
3950000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2471000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2254000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4417000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3950000 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1000 usd
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
1000 usd
CY2022Q2 artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-21000 usd
CY2021Q2 artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-1000 usd
artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-1000 usd
artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-2000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2449000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2252000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4414000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3947000 usd
CY2022Q2 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
7000 usd
CY2021Q2 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 usd
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
29000 usd
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-105000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-129000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-112000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-158000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2561000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2270000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4572000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3963000 usd
CY2022Q2 artl Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.06
CY2021Q2 artl Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.10
artl Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.10
artl Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.18
CY2022Q2 artl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
42456000 shares
CY2021Q2 artl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
23372000 shares
artl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
42379000 shares
artl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
21859000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1965000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-46000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
25780000 usd
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
519000 usd
CY2022Q2 artl Common Shares Issued For Commitment Fee Amount
CommonSharesIssuedForCommitmentFeeAmount
0 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
619000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-112000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1695000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2449000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23838000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8435000 usd
CY2021Q1 artl Common Shares Issued For Exercise Of Warrant Amount
CommonSharesIssuedForExerciseOfWarrantAmount
6016000 usd
CY2021Q1 artl Stock Issued During Period Value Issued For Services Three
StockIssuedDuringPeriodValueIssuedForServicesThree
11000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
13288000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1204000 usd
CY2021Q2 artl Stock Issued During Period Value Issued For Services Three
StockIssuedDuringPeriodValueIssuedForServicesThree
7000 usd
CY2021Q2 artl Stock Option Expense
StockOptionExpense
609000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2252000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-18000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
12838000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4414000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3947000 usd
artl Stock Based Compensation
StockBasedCompensation
1243000 usd
artl Stock Based Compensation
StockBasedCompensation
1146000 usd
artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-1000 usd
artl Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-2000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
19000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
2000 usd
artl Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
330000 usd
artl Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
-72000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-543000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-613000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
29000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
artl Fixed Cash Payments Related To Operating Leases
FixedCashPaymentsRelatedToOperatingLeases
22000 usd
artl Fixed Cash Payments Related To Operating Leases
FixedCashPaymentsRelatedToOperatingLeases
2000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4019000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3344000 usd
us-gaap Proceeds From Sale Of Trading Securities Heldforinvestment
ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
2687000 usd
us-gaap Proceeds From Sale Of Trading Securities Heldforinvestment
ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
4833000 usd
artl Investment In Available For Sale Securities
InvestmentInAvailableForSaleSecurities
-499000 usd
artl Investment In Available For Sale Securities
InvestmentInAvailableForSaleSecurities
0 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
7428000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4242000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3333000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1204000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
134000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6016000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-7000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-134000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7213000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-129000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
527000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12162000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5783000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12122000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6310000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
artl Initial Recognition Of Right Of Use Asset
InitialRecognitionOfRightOfUseAsset
20000 usd
artl Initial Recognition Of Right Of Use Asset
InitialRecognitionOfRightOfUseAsset
97000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
29000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
7211000 usd
CY2022Q2 artl Total Marketable Securities
TotalMarketableSecurities
7211 usd
CY2022Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1989000 usd
CY2022Q2 artl Total Available For Sale Securities
TotalAvailableForSaleSecurities
1989000 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
11951000 usd
CY2021Q4 artl Total Marketable Securities
TotalMarketableSecurities
11951 usd
CY2021Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1519000 usd
CY2021Q4 artl Total Available For Sale Securities
TotalAvailableForSaleSecurities
1519000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1200 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4720184 shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.62
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.63

Files In Submission

Name View Source Status
0001640334-22-001681-index-headers.html Edgar Link pending
0001640334-22-001681-index.html Edgar Link pending
0001640334-22-001681.txt Edgar Link pending
0001640334-22-001681-xbrl.zip Edgar Link pending
artl-20220630.xsd Edgar Link pending
artl_10q.htm Edgar Link pending
artl_ex311.htm Edgar Link pending
artl_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
artl-20220630_def.xml Edgar Link unprocessable
artl-20220630_lab.xml Edgar Link unprocessable
artl-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
artl_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
artl-20220630_cal.xml Edgar Link unprocessable